Citadel Advisors’s Zogenix, Inc. ZGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-45,210
Closed -$735K 15324
2021
Q4
$735K Sell
45,210
-54,940
-55% -$805K ﹤0.01% 8713
2021
Q3
$1.52M Buy
100,150
+44,037
+78% +$688K ﹤0.01% 7052
2021
Q2
$970K Sell
56,113
-64,254
-53% -$1.18M ﹤0.01% 8445
2021
Q1
$2.35M Sell
120,367
-25,501
-17% -$523K ﹤0.01% 6021
2020
Q4
$2.92M Sell
145,868
-387,477
-73% -$7.92M ﹤0.01% 4629
2020
Q3
$9.56M Buy
533,345
+385,944
+262% +$9.46M ﹤0.01% 2341
2020
Q2
$3.98M Buy
147,401
+84,876
+136% +$2.34M ﹤0.01% 3400
2020
Q1
$1.55M Buy
62,525
+53,912
+626% +$1.96M ﹤0.01% 4563
2019
Q4
$449K Sell
8,613
-234,513
-96% -$10.7M ﹤0.01% 6984
2019
Q3
$9.73M Buy
243,126
+13,990
+6% +$645K ﹤0.01% 2251
2019
Q2
$10.9M Buy
+229,136
New +$9.23M 0.01% 2076
2019
Q1
Sell
-8,311
Closed -$395K 10379
2018
Q4
$303K Sell
8,311
-196,822
-96% -$8.06M ﹤0.01% 7258
2018
Q3
$10.2M Buy
205,133
+93,510
+84% +$4.76M ﹤0.01% 2076
2018
Q2
$4.93M Buy
111,623
+37,576
+51% +$1.55M ﹤0.01% 2794
2018
Q1
$2.97M Buy
74,047
+61,778
+504% +$2.45M ﹤0.01% 3151
2017
Q4
$491K Sell
12,269
-613,943
-98% -$23.6M ﹤0.01% 5678
2017
Q3
$21.9M Buy
+626,212
New +$8.5M 0.02% 1012
2016
Q1
Sell
-31,323
Closed -$314K 9181
2015
Q4
$461K Sell
31,323
-37,852
-55% -$509K ﹤0.01% 4570
2015
Q3
$934K Buy
69,175
+68,652
+13,127% +$1.24M ﹤0.01% 3907
2015
Q2
$7K Sell
523
-175
-25% -$2.15K ﹤0.01% 8502
2015
Q1
$8K Sell
698
-23,894
-97% -$270K ﹤0.01% 8261
2014
Q4
$270K Buy
24,592
+22,553
+1,106% +$223K ﹤0.01% 5595
2014
Q3
$19K Buy
+2,039
New +$23.2K ﹤0.01% 7506
2014
Q2
Sell
-6,874
Closed -$156K 8665
2014
Q1
$156K Sell
6,874
-2,573
-27% -$83.8K ﹤0.01% 5768
2013
Q4
$260K Buy
+9,447
New +$212K ﹤0.01% 4752

Citadel Advisors's ZGNX Position: Q1 2022 in Review

Citadel Advisors sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 45,210 shares — an estimated $735K sold.

Citadel Advisors first reported a position in ZGNX in Q4 2013 and held it in 25 quarters. The position peaked at $21.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

  • Citadel Advisors reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 45,210 Zogenix, Inc. shares in Q1 2022, an estimated $735K.
  • Citadel Advisors first reported a position in Zogenix, Inc. in Q4 2013 and held it in 25 quarters.
  • Citadel Advisors's Zogenix, Inc. position peaked at $21.9M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.